Overview

• Germany's pharmaceutical sector forecasts 2.5% sales growth, 2.9% production increases, and 1,100 new jobs in 2025, driven by export demand and domestic market recovery.
• U.S. stockpiling ahead of potential tariffs has boosted German pharma exports, with increased air freight shipments reported by Lufthansa Cargo and DHL.
• The U.S., Germany's largest pharma market, accounted for €27 billion in exports in 2024, nearly a quarter of the sector's total exports.
• Industry leaders warn that imposing U.S. tariffs on medical products could lead to short-term cuts, mid-term profitability challenges, and supply chain disruptions for essential inputs.
• Novartis and Sanofi CEOs have urged the EU to align drug prices with U.S. levels to sustain innovation and prevent a decline in Europe's pharmaceutical competitiveness.